← Leaderboards
Virend K Somers
University Of Iowa
$28,876,430
Attributed
$29,280,436
Total exposure
22
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,280,436 · 22
By mechanism
R01$27,543,102 · 11
R21$822,874 · 2
P01$659,352 · 1
M01$255,108 · 8
Top collaborators
- Prachi Singh2 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Craig D Ellermeier$8,497,526
Others in their field
Top investigators on “Cardiovascular Diseases”
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$145,558,149
- Judith S. Currier · University Of California Los Angeles$143,001,230
- David M Nathan · Massachusetts Institute Of Technology$141,671,512
- John M Lachin · George Washington University$139,991,329
- Judith S Hochman · New York University School Of Medicine$112,514,057
Research focus
Cardiovascular DiseasesHuman SubjectBlood PressureClinical ResearchHypertensionSleepCardiovascular SystemInsightPrevalenceNeuroregulationLinkAdipose TissueBaroreflexRisk FactorsObesityBlood VesselsCardiovascular Risk FactorMediator Of Activation ProteinReportingHourChronicProgramsMolecularMediating
Grant awards (73)
Community Based Genomic Medicine and Polygenic Scoring$834,052
R01 · FY2025 · HG · contact PI
Disrupted Sleep in Somali Americans â Implications for Hypertension Risk$769,588
R01 · FY2025 · HL · contact PI
Disrupted Sleep in Somali Americans â Implications for Hypertension Risk$759,797
R01 · FY2024 · HL · contact PI
Disrupted Sleep in Somali Americans â Implications for Hypertension Risk$781,437
R01 · FY2023 · HL · contact PI
Disrupted Sleep in Somali Americans â Implications for Hypertension Risk$787,153
R01 · FY2022 · HL · contact PI
Sleep Enhancement to Decrease Blood Pressure: A Randomized, Controlled Trial$772,678
R01 · FY2021 · HL · contact PI
Disease Mechanisms in Sleep Apnea$407,103
R01 · FY2021 · HL · contact PI
Sleep Enhancement to Decrease Blood Pressure: A Randomized, Controlled Trial$786,707
R01 · FY2020 · HL · contact PI
Sleep Apnea and Hypertrophic Cardiomyopathy - Implications for Arrhythmia and Sudden Death$733,151
R01 · FY2020 · HL · contact PI
Disease Mechanisms in Sleep Apnea$404,781
R01 · FY2020 · HL · contact PI
Sleep Enhancement to Decrease Blood Pressure: A Randomized, Controlled Trial$786,707
R01 · FY2019 · HL · contact PI
Sleep Apnea and Hypertrophic Cardiomyopathy - Implications for Arrhythmia and Sudden Death$741,922
R01 · FY2019 · HL · contact PI
Disease Mechanisms in Sleep Apnea$404,006
R01 · FY2019 · HL · contact PI
Sleep Enhancement to Decrease Blood Pressure: A Randomized, Controlled Trial$789,092
R01 · FY2018 · HL · contact PI
Sleep Apnea and Hypertrophic Cardiomyopathy - Implications for Arrhythmia and Sudden Death$780,322
R01 · FY2018 · HL · contact PI
Disease Mechanisms in Sleep Apnea$404,006
R01 · FY2018 · HL · contact PI
Sleep Enhancement to Decrease Blood Pressure: A Randomized, Controlled Trial$788,973
R01 · FY2017 · HL · contact PI
Sleep Apnea and Hypertrophic Cardiomyopathy - Implications for Arrhythmia and Sudden Death$785,928
R01 · FY2017 · HL · contact PI
Disease Mechanisms in Sleep Apnea$404,006
R01 · FY2017 · HL · contact PI
Sleep Restriction and Augmented Vascular Risk in Prehypertension$595,620
R01 · FY2016 · HL · contact PI
Interactions Between Obesity Risk and Insufficient Sleep$687,199
R01 · FY2015 · HL · contact PI
Sleep Restriction and Augmented Vascular Risk in Prehypertension$592,949
R01 · FY2015 · HL · contact PI
Interactions Between Obesity Risk and Insufficient Sleep$684,350
R01 · FY2014 · HL · contact PI
Sleep Restriction and Augmented Vascular Risk in Prehypertension$596,174
R01 · FY2014 · HL · contact PI
Disease Mechanisms in Sleep Apnea$389,550
R01 · FY2014 · HL · contact PI
Interactions Between Obesity Risk and Insufficient Sleep$664,796
R01 · FY2013 · HL · contact PI
Disease Mechanisms in Sleep Apnea$378,420
R01 · FY2013 · HL · contact PI
Interactions Between Obesity Risk and Insufficient Sleep$698,317
R01 · FY2012 · HL · contact PI
Sleep Restriction and Augmented Vascular Risk in Prehypertension$608,340
R01 · FY2012 · HL · contact PI
Disease Mechanisms in Sleep Apnea$397,500
R01 · FY2012 · HL · contact PI
Adipokines and Cardiovascular Disease in Diabetes$567,825
R01 · FY2010 · HL · contact PI
Sleep Deprivation and Energy Balance$188,875
R21 · FY2010 · HL · contact PI
Adipokines and Cardiovascular Disease in Diabetes$592,986
R01 · FY2009 · HL · contact PI
Sleep Deprivation and Energy Balance$218,474
R21 · FY2009 · HL · contact PI
Molecular Mechanisms Mediating Resistance to Leptin Signaling During Fat Gain$188,875
R21 · FY2009 · DK · contact PI
Cardiovascular Disease Mechanisms in Sleep Apnea$349,641
R01 · FY2008 · HL · contact PI
Molecular Mechanisms Mediating Resistance to Leptin Signaling During Fat Gain$226,650
R21 · FY2008 · DK · contact PI
Cardiovascular Disease Mechanisms in Sleep Apnea$349,641
R01 · FY2007 · HL · contact PI
Fat Gain and Cardiovascular Disease Mechanisms$346,086
R01 · FY2007 · HL · contact PI
Cardiovascular Disease Mechanisms in Sleep Apnea$360,084
R01 · FY2006 · HL · contact PI
Fat Gain and Cardiovascular Disease Mechanisms$356,423
R01 · FY2006 · HL · contact PI
Neural Circulatory Control in the Long QT Syndrome$317,485
R01 · FY2006 · HL · contact PI
Cardiovascular Disease Mechanisms in Sleep Apnea$368,750
R01 · FY2005 · HL
Fat Gain and Cardiovascular Disease Mechanisms$365,000
R01 · FY2005 · HL
Neural Circulatory Control in the Long QT Syndrome$325,125
R01 · FY2005 · HL
GENETIC BACKGROUND OF CARDIOVASCULAR AND SLEEP DISORDERS IN HUMANS$49,521
M01 · FY2005 · RR
CARDIOVASCULAR DISEASE MECHANISMS IN SLEEP APNEA$31,277
M01 · FY2005 · RR
SPECTRAL OSCILLATIONS IN NEURAL CIRCULATORY CONTROL IN HUMANS$7,819
M01 · FY2005 · RR
FAT GAIN AND CARDIOVASCULAR DISEASE MECHANISMS$3,554
M01 · FY2005 · RR
NEURAL CIRCULATORY CONTROL IN THE LONG QT SYNDROME$948
M01 · FY2005 · RR
Cardiovascular Disease Mechanisms in Sleep Apnea$368,750
R01 · FY2004 · HL
Fat Gain and Cardiovascular Disease Mechanisms$365,000
R01 · FY2004 · HL
Neural Circulatory Control in the Long QT Syndrome$325,125
R01 · FY2004 · HL
Genetic Background of Cardiovascular and Sleep Disorders in Humans$65,583
M01 · FY2004 · RR
Cardiovascular Disease Mechanisms in Sleep Apnea$55,387
M01 · FY2004 · RR
Mechanisms Mediating Cardiovascular Responses to Smoking$22,016
M01 · FY2004 · RR
Spectral Oscillations in Neural Circulatory Control$11,819
M01 · FY2004 · RR
Neural Circulatory Control in the Long QT Syndrome$5,330
M01 · FY2004 · RR
Interaction Between Leptin &Neural Circulatory Control$927
M01 · FY2004 · RR
Neural Circulatory Control in Patients with Syncope$927
M01 · FY2004 · RR
Fat Gain and Cardiovascular Disease Mechanisms$365,000
R01 · FY2003 · HL
Neural Circulatory Control in the Long QT Syndrome$325,125
R01 · FY2003 · HL
MECHANISMS MEDIATING CARDIOVASCULAR RESPONSES TO SMOKING$280,948
R01 · FY2003 · HL
Neural Circulatory Control in the Long QT Syndrome$325,125
R01 · FY2002 · HL
CARDIOVASCULAR DISEASE MECHANISMS IN SLEEP APNEA$292,039
R01 · FY2002 · HL
MECHANISMS MEDIATING CARDIOVASCULAR RESPONSES TO SMOKING$277,373
R01 · FY2002 · HL
LEPTIN AND REFLEX CONTROL OF AUTONOMIC REGULATION$233,291
P01 · FY2002 · HL
CARDIOVASCULAR DISEASE MECHANISMS IN SLEEP APNEA$285,749
R01 · FY2001 · HL
MECHANISMS MEDIATING CARDIOVASCULAR RESPONSES TO SMOKING$271,193
R01 · FY2001 · HL
LEPTIN AND REFLEX CONTROL OF AUTONOMIC REGULATION$233,291
P01 · FY2001 · HL
CARDIOVASCULAR DISEASE MECHANISMS IN SLEEP APNEA$282,810
R01 · FY2000 · HL
MECHANISMS MEDIATING CARDIOVASCULAR RESPONSES TO SMOKING$265,195
R01 · FY2000 · HL
LEPTIN AND REFLEX CONTROL OF AUTONOMIC REGULATION$192,770
P01 · FY2000 · HL